Working… Menu

QUILT-3.002: ALT-803 in Patients With Relapse/Refractory iNHL in Conjunction With Rituximab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02384954
Recruitment Status : Terminated (Change in drug product development strategy.)
First Posted : March 10, 2015
Last Update Posted : February 15, 2021
Information provided by (Responsible Party):
Altor BioScience

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 31, 2020
Actual Study Completion Date : December 31, 2020